StonvexLoading…
StonvexStonvexStonvexCore line items from LAD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $37.63B | $36.19B | $31.04B | $28.19B |
Operating Income | $1.59B | $1.57B | $1.69B | $1.94B |
Net Income | $819.60M | $796.70M | $1.00B | $1.25B |
EPS (Diluted) | $32.32 | $29.45 | $36.29 | $44.17 |
Total Assets | $25.11B | $23.12B | $19.63B | $15.01B |
Total Liabilities | $18.48B | $16.45B | $13.35B | $9.76B |
Cash & Equivalents | $391.30M | $445.80M | $972.00M | $271.50M |
Free Cash Flow OCF − CapEx | $5.80M | $73.70M | $-702.60M | $-913.20M |
Shares Outstanding | 23.50M | 26.40M | 27.40M | 27.30M |